The Eighteenth John Vane Memorial Symposium (Mar 2023) on Prostacyclin Science and Pulmonary Vascular Disease

17-18 March 2023

research models

The John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease was held at the Royal Society, London, UK again this year and it was wonderful to see everyone in person!


View the 2023 Programme


Those of you who attended this year will be able to revisit the presentations using the links below (your password has been emailed to you).  We hope you enjoy.

Chris Thiemermann - Welcome


Marc Humbert - 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH


Vallerie Mclaughlin - Risk Management and Medical Therapy for PH


Ardeschir Ghofrani - New Study Designs for Clinical Trials in PH


David Kieley - Multimodality Imaging and AI in the Diagnosis and Assessment of PH


Jim White - Freedom EV: Risk Scores, Events and Mortality


Sandeep Sahay - Assessed versus Actual Risk of PH?


Franck Rahaghi - What is a Disease-Modifying Therapy in PH?


Vinicio de Jesus Perez - Global Perspective of Patient Care Access


John Ryan - Patient Perspective in Treatment Planning in PH


George Giannakoulas - Pulmonary Hypertension in Congenital Heart Disease?


Martin Wilkins - The use of remote haemodynamic monitoring in drug development


Michele D’Alto - Combination therapies in PAH: Are Prostacyclins dispensable?


Mark Toshner - Autoimmunity and Idiopathic Pulmonary Hypertension


Dario Vizza - Pulmonary Hypertension in Patients with COPD


Allan Lawrie - Molecular Subsets of Pulmonary Hypertension

Website design and development by Adept Lab photography by: Gary Shwartz